相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。BRCA1/2 testing: therapeutic implications for breast cancer management
Nadine M. Tung et al.
BRITISH JOURNAL OF CANCER (2018)
Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer
Z. F. Jiang et al.
LIFE SCIENCES (2018)
Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy
Martina Bonechi et al.
Oncotarget (2018)
Early detection of pemetrexed-induced inhibition of thymidylate synthase in non-small cell lung cancer with FLT-PET imaging
Xiao Chen et al.
ONCOTARGET (2017)
The Half-Life of Serum Thymidine Kinase 1 Concentration Is an Important Tool for Monitoring Surgical Response in Patients with Lung Cancer: A Meta-Analysis
Xudan Lou et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2017)
Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt's lymphoma and acute lymphoblastic leukemia
Evita G. Weagel et al.
ONCOTARGETS AND THERAPY (2017)
Preclinical Applications of 3 '-Deoxy-3 '-[F-18]Fluoro-thymidine in Oncology - A Systematic Review
Sonja Schelhaas et al.
THERANOSTICS (2017)
Dual addressing of thymidine synthesis pathways for effective targeting of proliferating melanoma
Tara Miran et al.
CANCER MEDICINE (2017)
Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib
Nusayba Bagegni et al.
BREAST CANCER RESEARCH (2017)
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials
Alex Tsodikov et al.
ANNALS OF INTERNAL MEDICINE (2017)
Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people
Yu Wang et al.
CANCER BIOMARKERS (2016)
A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease
J. Kiran Kumar et al.
TUMOR BIOLOGY (2016)
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent-Update 2013
Axel Heidenreich et al.
EUROPEAN UROLOGY (2014)
Comparison of diagnostic and prognostic performance of two assays measuring thymidine kinase 1 activity in serum of breast cancer patients
Benjamin Nisman et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2013)
Limits of [18F]-FLT PET as a Biomarker of Proliferation in Oncology
Eliot T. McKinley et al.
PLOS ONE (2013)
High baseline serum thymidine kinase 1 level predicts unfavorable outcome in patients with follicular lymphoma
Vit Prochazka et al.
LEUKEMIA & LYMPHOMA (2012)
Thymidine Kinase 1 Upregulation Is an Early Event in Breast Tumor Formation
Melissa M. Alegre et al.
JOURNAL OF ONCOLOGY (2012)
Changes in serum thymidine kinase 1 levels during chemotherapy correlate with objective response in patients with advanced gastric cancer
Yongping Liu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2011)
Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia
C. F. R. Källander et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings
Yan Chen et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2010)
Regulation and Functional Contribution of Thymidine Kinase 1 in Repair of DNA Damage
Yen-Ling Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Serum thymidine kinase 1 concentration as a prognostic factor of chemotherapy-treated non-Hodgkin's lymphoma patients
Zhu-Lin Pan et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Enzymatic Regulation of Cytosolic Thymidine Kinase 1 and Mitochondrial Thymidine Kinase 2: A Mini Review
B. Munch-Petersen
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2010)
Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan™ assays
Fabio Gasparri et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2009)
Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors
Wei Xu et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
Imaging of cell proliferation: Status and prospects
James R. Bading et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors
Rolf F. Barth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Thymidine kinase 1 - A prognostic and diagnostic indicator in ALL and AML patients
K. L. O'Neill et al.
LEUKEMIA (2007)
Genetic and biochemical modulation of 5-fluorouracil through the overexpression of thymidine kinase: an in-vitro study
Raphaelle Fanciullino et al.
ANTI-CANCER DRUGS (2006)
Sensitive nonradiometric method for determining thymidine kinase I activity
A Öhrvik et al.
CLINICAL CHEMISTRY (2004)
Thymidine kinase in epithelial ovarian cancer: Relationship with the other pyrimidine pathway enzymes
R Fujiwaki et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
The half-life of thymidine kinase 1 in serum measured by ECL dot blot: a potential marker for monitoring the response to surgery of patients with gastric cancer
L Zou et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2002)
The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody
Q He et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2000)
分享论文
